Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve the Un-audited ....
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Akums Drugs and Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Thursday, 13 November 2025. The main agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2025 (Q2 and H1 FY26). The intimation was filed under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements. Signed by Company Secretary Dharamvir Malik on 8 November 2025.
This is a routine regulatory disclosure with no direct impact on shareholders. Investors should watch for the Q2/H1 FY26 results announcement on or after 13 November 2025, which may influence short-term stock movement depending on the numbers reported.